Dear colleagues and friends,

Since the first Post-Chicago Meeting on Melanoma / Skin Cancer took place in 2011, it has attracted up to 580 participants each year from all over the world. The interactive congress offers a comprehensive overview on all new developments in melanoma diagnostics and therapy and a direct communication with the world´s leading experts in these fields.

Presently, there are many new developments in melanoma diagnostics and treatment. New devices may enable a more precise diagnostics of primary melanoma and allow earlier detection. For metastatic melanoma, there is a rapid change of therapeutic approaches. New drugs like BRAF- and MEK-inhibitors and CTLA4 and PD1-antibodies are already established in melanoma treatment. However, it remains an open question how to combine them and how they should be sequentially applied. Additionally, the significance of other drugs and vaccines like T-VEC has still to be determined.

Nevertheless, it will be the main target for all of us to choose the right patients for the right drugs! The aim of the Interdisciplinary Global Conference on Developing New Treatments for Melanoma / Skin Cancer in Munich is to grant a deep overall insight into the development of new drugs for melanoma and other cutaneous malignancies. The lively interaction of clinicians, as well as experts in translational and basic research, and representatives of the pharmaceutical industry, guarantees a successful outcome for every participant.

International key opinion leaders on melanoma will be invited to give an overview throughout specified presentations, to present latest clinical trial results, and to discuss on exciting new drugs with the audience. In addition to the scientific value of this meeting, every participant may seize the given opportunity to interact with experts in a familiar setting in one of the most interesting cities of Germany.

Please join us for this event and submit your own studies and case presentations as free communications and as posters.

We look forward to welcoming you in Munich in June 2016!

  Axel Hauschild, MD                      Claus Garbe, MD
                          Congress Presidents